Do Angiotensin-converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Have Similar Effects in the Improvement of Left Ventricular Dysfunction after Myocardial Infarction in Japanese?

被引：0
作者：
Miura, Shin-ichiro [1 ]
Saku, Keijiro [1 ]
机构：
[1] Fukuoka Univ, Sch Med, Dept Cardiol, Fukuoka 81401, Japan
来源：
INTERNAL MEDICINE | 2009年 / 48卷 / 22期
关键词：
angiotensin-converting enzyme inhibitors; angiotensin II receptor blockers; myocardial infarction; left ventricular remodeling; LOSARTAN; VALSARTAN; MORTALITY; MORBIDITY; CAPTOPRIL;
D O I：
10.2169/internalmedicine.48.2627
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1929 / 1930
页数：2
相关论文
共 11 条
[1]  
Agodoa L, 2007, J HYPERTENS, V25, P951
[2]   Differences in tissue angiotensin II-forming pathways by species and organs in vitro [J].
Akasu, M ;
Urata, H ;
Kinoshita, A ;
Sasaguri, M ;
Ideishi, M ;
Arakawa, K .
HYPERTENSION, 1998, 32 (03) :514-520
[3]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[4]   Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[5]   Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial [J].
Dickstein, K ;
Kjekshus, J .
LANCET, 2002, 360 (9335) :752-760
[6]   Recent progress in angiotensin II type 2 receptor research in the cardiovascular system [J].
Horiuchi, M ;
Akishita, M ;
Dzau, VJ .
HYPERTENSION, 1999, 33 (02) :613-621
[7]   Angiotensin II Receptor Blocker as an Inverse Agonist: A Current Perspective [J].
Miura, Shin-ichiro ;
Fujino, Masahiro ;
Saku, Keijiro .
CURRENT HYPERTENSION REVIEWS, 2005, 1 (02) :115-121
[8]  
Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15
[9]   Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both [J].
Pfeffer, MA ;
McMurray, JJV ;
Velazquez, EJ ;
Rouleau, JL ;
Kober, L ;
Maggioni, AP ;
Solomon, SD ;
Swedberg, K ;
Van de Werf, F ;
White, H ;
Leimberger, JD ;
Henis, M ;
Edwards, S ;
Zelenkofske, S ;
Sellers, MA ;
Califf, RM ;
Aylward, P ;
Armstrong, P ;
Barvik, S ;
Belenkov, Y ;
Dalby, A ;
Diaz, R ;
Drexler, H ;
Ertl, G ;
Francis, G ;
Hampton, J ;
Harsanyi, A ;
Kvasnicka, J ;
Mareev, V ;
Marin-Neto, J ;
Murin, J ;
Myers, M ;
Nordlander, R ;
Opolski, G ;
Soler-Soler, J ;
Spac, J ;
Stefenelli, T ;
Sugrue, D ;
Van Gilst, W ;
Varshavsky, S ;
Weaver, D ;
Zannad, F ;
Aguilar, D ;
Alvarez, A ;
Al-Taweel, M ;
Anavekar, N ;
Finn, P ;
Lopez-Jimenez, F ;
Mercier, R ;
Lewis, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (20) :1893-1906
[10]   Inhibitory Effect of Valsartan Against Progression of Left Ventricular Dysfunction After Myocardial Infarction - T-VENTURE Study [J].
Suzuki, Hiroshi ;
Geshi, Eiichi ;
Nanjyo, Shuji ;
Nakano, Hajime ;
Yamazaki, Jyunichi ;
Sato, Naoki ;
Tanaka, Keiji ;
Takano, Teruo ;
Yagi, Hidenori ;
Shibata, Takahiro ;
Mochizuki, Seibu ;
Katagiri, Takashi .
CIRCULATION JOURNAL, 2009, 73 (05) :918-924
12